
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65630 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Fluconazole Related Compound C (1,1'-(1,3-phenylene)di(1H-1,2,4-triazole))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C10H8N6Color and Shape:White PowderMolecular weight:212.08104Labetalol Related Compound A (2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzoic acid hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C19H23NO4·HClColor and Shape:Off-White SolidMolecular weight:365.13939Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSHClColor and Shape:White Off-White PowderMolecular weight:315.16569O-Thienylethyl Rotigotine Hydrochloride ((S)-N-propyl-5-(2-(thiophen-2-yl)ethoxy)-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C25H32ClNOS2Color and Shape:Pale Beige SolidMolecular weight:461.16138Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C12H14FN·HClColor and Shape:White PowderMolecular weight:191.11103Metoprolol Related Compound E (3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C12H18O4Color and Shape:White Coarse Powder Semi-SolidMolecular weight:226.12051Duloxetine Related Compound A ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19NOS·HClColor and Shape:Off-White SolidMolecular weight:333.88Rotigotine Related Compound K (7,8-Dihydronaphthalen-1-ol)
CAS:Monophenols not elsewhere specified or includedFormula:C10H10OColor and Shape:White Grey Brown Crystalline SolidMolecular weight:146.07316Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White PowderNilotinib Related Compound C (3-Amino-4-methylbenzoic acid)
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, not elsewhere specified or includedFormula:C8H9NO2Color and Shape:White Beige PowderMolecular weight:151.16Metoprolol Succinate
CAS:Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:(C15H25NO3)2·C4H6O4Color and Shape:White Off-White PowderMolecular weight:534.366892,4-Disulfamyl-5-Trifluoromethylaniline
CAS:Sulfonamides, nesoiFormula:C7H8F3N3O4S2Color and Shape:PowderMolecular weight:318.99083Rivaroxaban Open Ring Methylamine ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H21N3O3Color and Shape:White Off-White SolidMolecular weight:279.15829Particle Count Set (2 blanks (28 mL each) and 2 suspensions (25 mL each))
Polystyrene,nesoiColor and Shape:Clear Milky Liquid SuspensionRotigotine ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSColor and Shape:White Beige PowderMolecular weight:315.16569Omeprazole Related Compound F and G Mixture
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C16H13N3O2SColor and Shape:Dark Brown PowderMolecular weight:311.07285Salmeterol Xinafoate
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormula:C25H37NO4·C11H8O3Color and Shape:White PowderMolecular weight:415.27226Fluvoxamine Maleate
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C15H21F3N2O2·C4H4O4Color and Shape:White Off-White Crystalline PowderMolecular weight:318.15551Dichloroaniline (3,4-Dichloroaniline)
CAS:Aniline derivatives and their saltsFormula:C6H5Cl2NColor and Shape:Light Brown Off-White CrystalsMolecular weight:160.9799Apixaban Related Compound H (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C27H29ClN4O5Color and Shape:Off-White PowderMolecular weight:524.18265

